PATTERSON MATTHEW R (Chief Executive Officer) sold 11.3% of their position (14.43K shares) of AUDENTES THERAPEUTICS, INC. on the open market
Open‑market sale worth $432.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2019ACC: 0001209191-19-056113
DirectorOfficer· Chief Executive Officer
Since Jul 2018
-14.43K
Net shares
Net seller
$432.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14.43K acquired · 28.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.43K
Price / share
$9.50
Trade value
$137.05K
% of position
12.7%
11/8/2019
113.39K→127.82K
Common Stock
Direct
Shares
−14.43K
Price / share
$30.00
Trade value
$432.78K
% of position
11.3%
11/8/2019
127.82K→113.39K
Total
Net shares
+0.00
Net value
-$295.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/8/2019 | M · Option Exercise | +14.43K | $9.50 | $137.05K | 12.7% | 113.39K | 127.82K |
| Common Stock Direct | 11/8/2019 | S · Sale | −14.43K | $30.00 | $432.78K | 11.3% | 127.82K | 113.39K |
| Total | +0.00 | -$295.73K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
14.43K shares
Shares
−14.43K
Strike price
9.50
Held after
155.39K
Exercisable
—
11/8/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock14.43K shares | 11/8/2019 | M · Option Exercise | −14.43K | 9.50 | — | 155.39K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned171.81K
Total
171.81K indirect171.81K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 171.81K | Indirect |
| Total | 171.81K | 171.81K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported